March Altus Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $760K | Sell |
6,199
-2,400
| -28% | -$294K | 4.75% | 10 |
|
|
2016
Q2 | $1M | Hold |
8,599
| – | – | 7.76% | 7 |
|
|
2016
Q1 | $1.2M | Hold |
8,599
| – | – | 12.38% | 5 |
|
|
2015
Q4 | $1.64M | Buy |
+8,599
| New | +$1.64M | 15.09% | 1 |
|
|
2015
Q3 | – | Sell |
-5,949
| Closed | -$1.08M | – | 24 |
|
|
2015
Q2 | $1.08M | Buy |
5,949
+2,269
| +62% | +$410K | 6.25% | 6 |
|
|
2015
Q1 | $638K | Sell |
3,680
-62,280
| -94% | -$10.8M | 4.01% | 15 |
|
|
2014
Q4 | $12.2M | Sell |
65,960
-1,120
| -2% | -$207K | 5.57% | 6 |
|
|
2014
Q3 | $11.1M | Sell |
67,080
-2,169
| -3% | -$360K | 4.43% | 9 |
|
|
2014
Q2 | $10.8M | Sell |
69,249
-4,862
| -7% | -$760K | 3.97% | 9 |
|
|
2014
Q1 | $11.3M | Sell |
74,111
-17,300
| -19% | -$2.63M | 3.62% | 12 |
|
|
2013
Q4 | $12.2M | Buy |
+91,411
| New | +$12.2M | 3.68% | 9 |
|